Work

Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes

Year: 2025

Type: article

Study design: Observational Study

Source: Annals of Internal Medicine

DOI: 10.7326/annals-24-00775

Authors: Anum Saeed, Suresh R. Mulukutla, Floyd Thoma, Lara Lemon, Agnes Koczo, Steven Reis, Oscar Marroquin, Kevin Kip

Institutions: University of Pittsburgh, UPMC Health System, University of Pittsburgh Medical Center

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4411335785

FWCI: 4.846

Cites: 39

Cited by: 8

Related to: 10